1. Diagnosis of extra-genital Chlamydia and/or Neisseria gonorrhoeae infections by VERSANT® CT/GC DNA 1.0 assay
- Author
-
MARANGONI, ANTONELLA, FOSCHI, CLAUDIO, CEVENINI, ROBERTO, Nardini, P., D\'Antuono, A., Compri, M., Macca, F., Kintrili, A., Banzola, N., Filippini, A., Marangoni, A, Foschi, C., Nardini, P., D\'Antuono, A., Compri, M., Macca, F., Kintrili, A., Banzola, N., Filippini, A., and Cevenini, R.
- Subjects
Chlamydia trachomati ,extragenital infection ,NAAT ,Versant CT/GC Assay ,Neisseria gonorrhoeae - Abstract
Objectives Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) infections still represent an increasing problem of public health, worldwide. Although unsafe anal and pharyngeal intercourses are common part of sexual repertoires and different cases of extragenital CT/GC infections are reported, extragenital specimens have not been cleared yet for nucleic acid amplification testing (NAAT). For that reason, many laboratories have performed their own validation studies in order to provide results for the clinical management. In this study, Versant CT/GC DNA 1.0 Assay (Siemens) performances were evaluated by testing rectal and pharyngeal swabs collected from a high STD-risk population. Methods From February 2013 to October 2013, urine samples, pharyngeal and anorectal swabs were collected from patients attending the STD Outpatients Clinic of St. Orsola Hospital, Bologna. The patients were enrolled because of a history of unsafe anal and/or oral intercourses. Swabs and urine specimens were tested by Versant CT/GC 1.0 Assay. GC positive results were confirmed using a “home made’ PCR assay targeting PorA gene. CT positive samples were further genotyped by RFLP analysis. Moreover, microbiological investigations for the main STDs (syphilis, HIV, HCV, HBV) were performed. Finally, Chi2 test and Student’s t test were performed and a P value
- Published
- 2014